Here in the U.S., card fraud is rampant. In fact, according to a recent Barclay’s report published in Security Magazine, 47 percent of the world’s credit card fraud happens in the U.S., even though Americans account for just 24 percent of total credit card volume worldwide.While technologies such as EMV and tokenization will eventually play a key role in curtailing U.S. card fraud, experts agree that their best weapon against this threat is an informed consumer.“In life, information is powerful,” said Bill Freer, risk manager for CO-OP Financial Services. “Nowhere is this better illustrated than in the fight against card fraud. Teaching members proper security protocols should be a top priority for every credit union, especially with so many misperceptions out there about how fraud occurs.”Myth #1: I’m Safer On-Site Than OnlineAccording to Freer, the number one misperception most consumers have about card fraud is that online transactions pose the greatest risk. “Online fraud is always a concern, but most of the fraud we see occurs because of skimming devices and malware at merchant sites and ATMs,” he said. “These tools allow fraudsters to record all the card data information they need often without ever touching a physical card.” continue reading » 6SHARESShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblr
IOWA CITY — A clinical trial for an experimental COVID-19 drug is now underway at the University of Iowa Hospitals and Clinics. The hospital started enrolling patients last week to try Remdesivir.There have been promising results in lab tests, but it’s still not clear how safe or effective the drug is for people. Dr. Dilek Ince, a clinical professor of Infectious Diseases, is leading the research team at the hospital.“In actual lab trials, in lab studies, it’s shown to be very potent, very effective against multiple coronaviruses, including…SARS-coronavirus-2, the virus that causes COVID-19,” she says.There are currently no FDA-approved drugs to specifically treat COVID-19. In the meantime, physicians and patients around the world are testing experimental treatments. Hospitalized patients can qualify the trial if they don’t have certain liver or kidney issues. Ince says patients are willing to try it, but they have questions.“Is it really going to help me? That’s hard to know, right?” Ince says. “So that’s why we tell them, ‘You know, under lab conditions it seems like this drug should help you, but that’s why we need the clinical trials because in the real world, we do not if it’s really going to help.’”Patients who agree to participate in the trial will be given the drug being tested or a placebo for up to 10 days.
Frank Lampard 1 Frank Lampard’s eagerly awaited debut for New York City FC has been delayed after the former Chelsea midfielder picked up a leg injury in training.Lampard had been expected to make his Major League Soccer bow in Sunday’s match against Toronto FC, but suffered a calf strain while preparing for the Yankee Stadium encounter.Chelsea’s all-time leading goalscorer, who played for Manchester City during the 2014-15 Premier League season after leaving the Blues at the end of the previous campaign, could now feature in next Sunday’s game against New England Revolution.“I’m hugely disappointed to be missing out on Sunday’s game, which I have been really looking forward to. I’ve been feeling great in training and have loved working with the squad. Unfortunately I sustained a small strain to my calf during a session,” Lampard told his club’s official website.“Whilst I’ve been taking it day by day since then and have been involved in light training, I’ve just been advised by the medical team that it needs a few days’ rest for it to heal fully.“As I say, it’s personally very disappointing for me but these things happen in football. The good news is that I should be back in full training next week.“While I was desperate to play a role on Sunday, I have to take the advice of our medical team to let it heal and not risk further injury so I can get back on the pitch and play a full role as soon as possible.”The former England midfielder signed for the then newly formed MLS side in July last year but delayed his stateside arrival to help City finish runners-up to Chelsea in the recently-completed Premier League campaign.